This eases the user's understanding of the market thoroughly, while also gaining knowledge about Anxiety Disorder Treatment market opportunities and the dominant players Pfizer Inc, Merck KGaA, Sanofi ...
Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...
Following the recent U.S. elections, domestic equity ETFs experienced a surge in inflows, largely directed at large-cap core ...
DelveInsight's Glucose Syrup Market Insights report provides the current and forecast market analysis, individual leading ...
The "Diabetes Care Nutrition Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application" report has been added to ResearchAndMarkets.com's ...
The Saudi Arabia Pharmaceutical Drugs market has been expanding significantly in recent years, driven by various key factors like increased demand for its products, expanding customer base, and ...
The first payment of $25 million will be triggered if Royalty Pharma (RP) receives $240 million or more in royalty payments from GSK based on 2024 TRELEGY global net sales, which we expect would occur ...
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback